I am a
Home I AM A Search Login

Papers of the Week


2020 Jan


Oral Dis


26


1

Pharmacotherapy in relieving the symptoms of burning mouth syndrome: A 1-year follow-up study.

Authors

Paudel D, Utsunomiya M, Yoshida K, Giri S, Uehara O, Matsuoka H, Chiba I, Toyofuku A, Abiko Y
Oral Dis. 2020 Jan; 26(1):193-199.
PMID: 31705718.

Abstract

Burning mouth syndrome (BMS) is a chronic intraoral burning sensation with no identifiable causes. In this study, we aim to demonstrate the effectiveness of treatment strategy using ethyl loflazepate monotherapy or in combination with milnacipran or amitriptyline.